240 related articles for article (PubMed ID: 26492560)
41. [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
Liu YJ; Wu DP; Li CX; He J; Qiu QC; Zhang XG
Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):835-8. PubMed ID: 17217750
[TBL] [Abstract][Full Text] [Related]
42. Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation.
Park JH; Lee HJ; Kim SR; Song GW; Lee SK; Park SY; Kim KC; Hwang SH; Park JS
Korean J Intern Med; 2014 Sep; 29(5):630-6. PubMed ID: 25228839
[TBL] [Abstract][Full Text] [Related]
43. Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells.
Ukena SN; Grosse J; Mischak-Weissinger E; Buchholz S; Stadler M; Ganser A; Franzke A
Ann Hematol; 2011 Feb; 90(2):213-8. PubMed ID: 20859740
[TBL] [Abstract][Full Text] [Related]
44. Novel targets in the treatment of chronic graft-versus-host disease.
Im A; Hakim FT; Pavletic SZ
Leukemia; 2017 Mar; 31(3):543-554. PubMed ID: 27899803
[TBL] [Abstract][Full Text] [Related]
45. Monitoring of T-cell subsets in patients treated with anti-CD 25 antibody.
Praditpornsilpa K; Avihingsanon Y; Kupatawintu P; Songpanich S; Pisitkul T; Kansanabuch T; Eiam-Ong S; Chusil S; O-Charoen R; Tungsanga K
Transplant Proc; 2004 Mar; 36(2 Suppl):487S-491S. PubMed ID: 15041394
[TBL] [Abstract][Full Text] [Related]
46. Graft-vs-host disease after small bowel transplantation in children.
Andres AM; Santamaría ML; Ramos E; Sarriá J; Molina M; Hernandez F; Encinas JL; Larrauri J; Prieto G; Tovar JA
J Pediatr Surg; 2010 Feb; 45(2):330-6; discussion 336. PubMed ID: 20152346
[TBL] [Abstract][Full Text] [Related]
47. Improved survival and preserved antiviral responses after combination therapy with daclizumab and infliximab in steroid-refractory graft-versus-host disease.
Rao K; Rao A; Karlsson H; Jagani M; Veys P; Amrolia PJ
J Pediatr Hematol Oncol; 2009 Jun; 31(6):456-61. PubMed ID: 19648797
[TBL] [Abstract][Full Text] [Related]
48. Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease.
Fløisand Y; Lundin KEA; Lazarevic V; Kristiansen JD; Osnes LTN; Tjønnfjord GE; Reims HM; Gedde-Dahl T
Biol Blood Marrow Transplant; 2017 Jan; 23(1):172-175. PubMed ID: 27777142
[TBL] [Abstract][Full Text] [Related]
49. Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective.
Schub N; Günther A; Schrauder A; Claviez A; Ehlert C; Gramatzki M; Repp R
Bone Marrow Transplant; 2011 Jan; 46(1):143-7. PubMed ID: 20348971
[TBL] [Abstract][Full Text] [Related]
50. Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients.
Tao T; Ma X; Yang J; Zou JY; Ji SM; Tan YS; Gong W; Du F; Xu J; Ye CM; Tang XW; Wu DP; Xue SL
Blood Cancer J; 2015 Apr; 5(4):e308. PubMed ID: 25885428
[No Abstract] [Full Text] [Related]
51. Regulatory B10 cells display an altered homoeostasis in acute graft-versus-host disease.
Chakupurakal G; Garcia-Marquez MA; Shimabukuro-Vornhagen A; Kluth S; Schlosser H; Theurich S; Scheid C; Hallek M; Holtick U; von Bergwelt-Baildon M
Eur J Haematol; 2017 Feb; 98(2):128-133. PubMed ID: 27717015
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.
Martin PJ; Pei J; Gooley T; Anasetti C; Appelbaum FR; Deeg J; Hansen JA; Nash RA; Petersdorf EW; Storb R; Ghetie V; Schindler J; Vitetta ES
Biol Blood Marrow Transplant; 2004 Aug; 10(8):552-60. PubMed ID: 15282533
[TBL] [Abstract][Full Text] [Related]
53. [Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
Sun AN; Wu DP; Wang Y; Qiu HY; Jin ZM; Miao M; Tang XW; Fu ZZ; Ma X; Han Y; He GS; Chen SN; Xue SL; Zhao Y
Ai Zheng; 2006 Aug; 25(8):1019-22. PubMed ID: 16965686
[TBL] [Abstract][Full Text] [Related]
54. [Salvage treatment with infliximab of steroid-resistant graft-versus-host disease in allogeneic transplanted patients].
Motlló C; Ferrà C; López L; Morgades M; Batlle M; Ribera JM
Med Clin (Barc); 2011 Jun; 137(3):115-8. PubMed ID: 21543091
[TBL] [Abstract][Full Text] [Related]
55. Updated experience with inolimomab as treatment for corticosteroid-refractory acute graft-versus-host disease.
García-Cadenas I; Valcárcel D; Martino R; Piñana JL; Novelli S; Esquirol A; Garrido A; Moreno ME; Granell M; Moreno C; Saavedra S; Briones J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2013 Mar; 19(3):435-9. PubMed ID: 23178634
[TBL] [Abstract][Full Text] [Related]
56. Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.
Bleakley M; Heimfeld S; Loeb KR; Jones LA; Chaney C; Seropian S; Gooley TA; Sommermeyer F; Riddell SR; Shlomchik WD
J Clin Invest; 2015 Jul; 125(7):2677-89. PubMed ID: 26053664
[TBL] [Abstract][Full Text] [Related]
57. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
[TBL] [Abstract][Full Text] [Related]
58. Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation.
Yang J; Cheuk DK; Ha SY; Chiang AK; Lee TL; Ho MH; Chan GC
Pediatr Transplant; 2012 Nov; 16(7):771-8. PubMed ID: 22905718
[TBL] [Abstract][Full Text] [Related]
59. Unusual expansion of CD3+CD56+ natural killer T-like cells in peripheral blood after anticytokine treatment for graft-versus-host disease: A case report.
Sheng L; Fu H; Tan Y; Hu Y; Mu Q; Luo Y; Shi J; Cai Z; Ouyang G; Huang H
Medicine (Baltimore); 2018 Sep; 97(38):e12429. PubMed ID: 30235723
[TBL] [Abstract][Full Text] [Related]
60. T-cell chimerism is valuable in predicting early mortality in steroid-resistant acute graft-versus-host disease after myeloablative allogeneic cell transplantation.
Minculescu L; Madsen HO; Sengeløv H
Acta Haematol; 2014; 132(2):187-92. PubMed ID: 24603448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
